Halaven 1 mg Injection
$361.34
$289.07
Halaven 1 mg Injection is a targeted anticancer treatment specifically designed for patients battling metastatic breast cancer who have undergone at least two prior chemotherapy regimens. This medication is also indicated for the management of unresectable liposarcoma in patients who have previously received anthracycline therapy for advanced or metastatic disease, provided they are suitable candidates. Halaven functions by inhibiting the proliferation and dissemination of cancerous cells, ultimately aiming to halt disease progression. It is crucial for patients to be aware of potential side effects and contraindications, such as severe neutropenia, which can increase the risk of infection. This treatment should be administered under the supervision of a qualified healthcare provider to ensure optimal outcomes. Regular monitoring during therapy is essential to manage any adverse reactions effectively. As with any cancer treatment, discussing the benefits and risks with your healthcare team is vital for informed decision-making. With Halaven, patients can find hope in their fight against challenging cancer types, paving the way for improved quality of life.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Halaven 1 mg injection is primarily indicated for the treatment of metastatic breast cancer. This condition occurs when cancer cells spread beyond the breast to other parts of the body. The administration of Halaven can help manage symptoms and improve the quality of life for patients. It is often used when other therapies have not been effective.
• Patients receiving Halaven 1 mg injection may experience a reduction in pain and discomfort associated with metastatic breast cancer. The medication works by targeting cancer cells, potentially alleviating symptoms such as bone pain or swelling in affected areas. By addressing these symptoms, Halaven aids in enhancing daily functioning. It is a valuable option for those dealing with advanced stages of the disease.
• Halaven 1 mg injection is utilized when patients exhibit specific symptoms related to metastatic breast cancer, such as difficulty breathing or persistent cough. These symptoms can significantly impact a patient’s overall well-being. The use of Halaven aims to provide relief from these distressing symptoms, allowing individuals to engage more fully in their daily lives. This treatment can be part of a comprehensive care plan tailored to each patient's needs.
• In the context of metastatic breast cancer, Halaven 1 mg injection can also help address issues like loss of appetite and weight loss. These challenges often arise as the disease progresses, affecting a patient's nutritional status and energy levels. By managing these symptoms, Halaven contributes to a more stable condition for patients. This can facilitate better engagement with other supportive therapies and improve overall health outcomes.
Benefits
Metastatic breast cancer is a type of advanced breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, such as the bones, liver, lungs, or brain. Halaven 1 mg Injection is used when other medicines have not shown significant improvement and cancer has spread to other parts as well. It relieves the symptoms of breast cancer, such as breast lumps, bloody discharge from nipples, or changes in the shape or texture of the breast. Halaven 1 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you. Soft tissue sarcoma (liposarcoma): Soft tissue sarcoma is a group of cancers that develop in the soft tissues of the body, such as the muscles, fat, nerves, blood vessels, and connective tissues. This medicine is used for those who have received prior anthracycline-containing therapy and have not shown significant improvement. Anti-cancer Injection Halaven kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Side Effects
Halaven 1 mg Injection may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Breathlessness
• Risk of Infection
• Loss of appetite
• Headaches
• Numbness or tingling in toes and fingers
• Cough
• Feeling sick
• Diarrhoea
• Constipation
• Hair loss
• Body Pain
• Fever
• Fatigue
• Weight loss
Common Side Effects
• Sepsis
• Blood clot in veins
• Inflammation of the pancreas
• Liver Damage
• Protein and blood in your urine
• Severe skin reaction
• Bruising and bleeding
• Changes in heartbeat
How To Use
Halaven 1 mg is given intravenously (in a vein) or as an intravenous infusion over 2 to 5 minutes by a healthcare professional, doctor, or nurse in a hospital. The dosage and frequency of Halaven 1 mg/2 ml Prefilled Vial depend on various factors, including your weight and height, your health problems, and what type of cancer and condition you have. Your health professional may decrease your dose or delay your treatment if you experience serious side effects. While during the treatment, closely monitor the patient's blood cell count and peripheral neuropathy signs and symptoms.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Halaven Eribulin Injection. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Halaven 1 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Halaven 1 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Halaven 1 mg Injection. Halaven 1 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Halaven 1 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Halaven Eribulin Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Halaven 1 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Halaven 1 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Anti-cancer Injection Halaven may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Halaven 1 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Halaven 1 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Halaven 1 mg Injection.